glioblastoma
Conditions
Interventions
Case series (Intraoperative Yellow fluorescence + IORT ):None
Sponsors
General Hospital of Northern Theater Command
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. over 18 years old; 2. the history of malignant tumor and / or imaging / pathology were diagnosed as glioblastoma; 3. expected survival time more than 3 months; 4. the patients or their families agree to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Fluorescein sodium allergy; 2. intolerance of anesthesia and prone position; 3. patients with coagulation disorders; 4. patients who were unable to perform MRI/CT examination; 5. pregnant / lactation women; 6. mental illness that cannot be informed of informed consent; 7. other serious diseases that may lead to shorter survival period; 8. dyscrasia, organ function decompensation; 9. drug abuse and medical, psychological or social conditions may interfere with the patient's participation in the study or the assessment of the results of the study; 10. any allergy to the study of drug allergy or any drug allergy to this test is known or suspected; 11. any unstable state or condition that may jeopardize the safety and compliance of the patient; 12. Have participated in other clinical trials within 30 days prior to the screening visit in this study; 13. The researchers believe that the subject is unlikely to complete this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Local control rate;Postoperative symptom improvement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Life period;Surgery complication;Radiation complication;Karnofsky scale evaluation (KPS); | — |
Countries
China
Contacts
Public ContactLiang Guobiao
General Hospital of Northern Theater Command
Outcome results
None listed